Is Evogene Ltd. overvalued or undervalued?
As of August 31, 2022, Evogene Ltd. is considered a risky investment due to its negative price-to-book value of -2.01, low EV to EBIT and EV to EBITDA ratios, a valuation ratio significantly below industry average, and a year-to-date return of -34.60%, which underperforms the S&P 500's 12.22%.
As of 31 August 2022, the valuation grade for Evogene Ltd. moved from does not qualify to risky, indicating a significant shift in its perceived investment quality. The company appears to be overvalued given its negative price-to-book value of -2.01, an EV to EBIT ratio of 0.08, and an EV to EBITDA ratio of 0.09, which suggest that the market is pricing the stock unfavorably compared to its earnings potential. In comparison to peers, Evogene Ltd. has a valuation ratio of -0.7507, which is notably lower than the industry average. This further reinforces the notion that the company is not positioned favorably within its sector. Additionally, the stock has underperformed significantly against the S&P 500, with a year-to-date return of -34.60% compared to the index's 12.22%, highlighting the challenges facing the company in the current market environment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
